Beginning Cash (Quarterly)

Beginning Cash: The amount of cash reported by the company on its previous statement.

Sanuwave Health Inc. (SNWV) had Beginning Cash of $10.24M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$11.45M
Net Income	$10.32M
Cost of Goods Sold	$2.53M
Gross Profit	$8.93M
Operating Expenses	$9.98M
Operating Income	$1.47M
Non-Operating Income/Expense	$8.86M
Pre-Tax Income	$10.32M
Normalized Pre-Tax Income	$10.32M
Income after Taxes	$10.32M
Income from Continuous Operations	$10.32M
Consolidated Net Income/Loss	$10.32M
Normalized Income after Taxes	$10.32M
EBIT	$1.47M
EBITDA	$2.15M
Weighted-Average Shares Outstanding (Basic)	8.57M
Weighted-Average Shares Outstanding (Diluted)	9.14M
Earnings per Share (EPS) (Basic)	$1.20
Earnings per Share (EPS) (Diluted)	$0.46
Balance Sheet Financials
Current Assets	$22.63M
Property, Plant, and Equipment	$1.99M
Long-Term Assets	$12.97M
Total Assets	$35.60M
Current Liabilities	$19.58M
Long-Term Debt	$17.73M
Long-Term Liabilities	$18.95M
Total Liabilities	$38.53M
Common Equity	$-2.93M
Tangible Shareholders Equity	$-13.39M
Shareholders Equity	$-2.93M
Common Shares Outstanding	8.58M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$0.56M
Cash Flow from Investing Activities	$3.15M
Cash Flow from Financial Activities	$-4.35M
Beginning Cash	$10.24M
End Cash	$9.60M
Increase/Decrease in Cash	$-0.64M
Stock-Based Compensation	$3.51M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.16
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.20
Debt to Equity Ratio	-7.97
Gross Margin	77.94%
Operating Margin	12.81%
EBIT Margin	12.81%
EBITDA Margin	--
Pre-Tax Profit Margin	90.17%
Profit Margin	90.17%
Free Cash Flow	$3.71M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.32
Inventory Turnover	0.37
Receiveable Turnover	2.48
Days Sales in Receivables	36.31
Return on Equity	-352.27%
Return on Tangible Equity	-77.09%
Return on Assets	29.00%
Return on Investments	69.75%
Book Value Per Share	$-0.34
Free Cash Flow per Share	$0.41
Operating Cash Flow per Share	$0.06

Data from Zacks Investment Research, Inc.